248 related articles for article (PubMed ID: 19661559)
1. Doping control analysis of metamfepramone and two major metabolites using liquid chromatography-tandem mass spectrometry.
Thevis M; Sigmund G; Thomas A; Gougoulidis V; Rodchenkov G; Schänzer W
Eur J Mass Spectrom (Chichester); 2009; 15(4):507-15. PubMed ID: 19661559
[TBL] [Abstract][Full Text] [Related]
2. Doping control analysis of methoxyphenamine using liquid chromatography-tandem mass spectrometry.
Thevis M; Sigmund G; Koch A; Guddat S; Maurer HH; Schänzer W
Eur J Mass Spectrom (Chichester); 2008; 14(3):145-52. PubMed ID: 18708694
[TBL] [Abstract][Full Text] [Related]
3. Characterization of two major urinary metabolites of the PPARdelta-agonist GW1516 and implementation of the drug in routine doping controls.
Thevis M; Möller I; Thomas A; Beuck S; Rodchenkov G; Bornatsch W; Geyer H; Schänzer W
Anal Bioanal Chem; 2010 Apr; 396(7):2479-91. PubMed ID: 19946680
[TBL] [Abstract][Full Text] [Related]
4. Determination of N-desmethyl- and N-bisdesmethyl metabolites of Sibutramine in doping control analysis using liquid chromatography-tandem mass spectrometry.
Thevis M; Sigmund G; Schiffer AK; Schänzer W
Eur J Mass Spectrom (Chichester); 2006; 12(2):129-36. PubMed ID: 16723754
[TBL] [Abstract][Full Text] [Related]
5. Monitoring phosphodiesterase-4 inhibitors using liquid chromatography/(tandem) mass spectrometry in sports drug testing.
Thevis M; Krug O; Schänzer W
Rapid Commun Mass Spectrom; 2013 May; 27(9):993-1004. PubMed ID: 23592202
[TBL] [Abstract][Full Text] [Related]
6. Mass spectrometric characterization of a prolyl hydroxylase inhibitor GSK1278863, its bishydroxylated metabolite, and its implementation into routine doping controls.
Thevis M; Milosovich S; Licea-Perez H; Knecht D; Cavalier T; Schänzer W
Drug Test Anal; 2016 Aug; 8(8):858-63. PubMed ID: 26361079
[TBL] [Abstract][Full Text] [Related]
7. High-throughput screening for various classes of doping agents using a new 'dilute-and-shoot' liquid chromatography-tandem mass spectrometry multi-target approach.
Guddat S; Solymos E; Orlovius A; Thomas A; Sigmund G; Geyer H; Thevis M; Schänzer W
Drug Test Anal; 2011; 3(11-12):836-50. PubMed ID: 22135086
[TBL] [Abstract][Full Text] [Related]
8. Screening for benfluorex and its major urinary metabolites in routine doping controls.
Thevis M; Sigmund G; Gougoulidis V; Beuck S; Schlörer N; Thomas A; Kwiatkowska D; Pokrywka A; Schänzer W
Anal Bioanal Chem; 2011 Aug; 401(2):543-51. PubMed ID: 21116611
[TBL] [Abstract][Full Text] [Related]
9. Detection of new exemestane metabolites by liquid chromatography interfaced to electrospray-tandem mass spectrometry.
de Albuquerque Cavalcanti G; Carius Garrido B; Dias Leal F; Costa Padilha M; Mazzarino M; de la Torre X; Botre F; Radler de Aquino Neto F
J Steroid Biochem Mol Biol; 2011 Nov; 127(3-5):248-54. PubMed ID: 21924357
[TBL] [Abstract][Full Text] [Related]
10. Doping control analysis of trimetazidine and characterization of major metabolites using mass spectrometric approaches.
Sigmund G; Koch A; Orlovius AK; Guddat S; Thomas A; Schänzer W; Thevis M
Drug Test Anal; 2014; 6(11-12):1197-205. PubMed ID: 24913825
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of urinary prenylamine metabolites by means of liquid chromatography-tandem mass spectrometry.
Beuck S; Sigmund G; Koch A; Schänzer W; Pokrywka A; Kwiatkowska D; Thevis M
Drug Test Anal; 2012 Sep; 4(9):701-16. PubMed ID: 22786790
[TBL] [Abstract][Full Text] [Related]
12. In vitro metabolism studies on the selective androgen receptor modulator (SARM) LG121071 and its implementation into human doping controls using liquid chromatography-mass spectrometry.
Knoop A; Krug O; Vincenti M; Schänzer W; Thevis M
Eur J Mass Spectrom (Chichester); 2015; 21(1):27-36. PubMed ID: 25906032
[TBL] [Abstract][Full Text] [Related]
13. Doping control analysis of trenbolone and related compounds using liquid chromatography-tandem mass spectrometry.
Thevis M; Guddat S; Schänzer W
Steroids; 2009 Mar; 74(3):315-21. PubMed ID: 19007801
[TBL] [Abstract][Full Text] [Related]
14. Ultra high performance liquid chromatography tandem mass spectrometry determination and profiling of prohibited steroids in human biological matrices. A review.
Gosetti F; Mazzucco E; Gennaro MC; Marengo E
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May; 927():22-36. PubMed ID: 23317577
[TBL] [Abstract][Full Text] [Related]
15. High-throughput and sensitive screening by ultra-performance liquid chromatography tandem mass spectrometry of diuretics and other doping agents.
Ventura R; Roig M; Montfort N; Sáez P; Bergés R; Segura J
Eur J Mass Spectrom (Chichester); 2008; 14(3):191-200. PubMed ID: 18708699
[TBL] [Abstract][Full Text] [Related]
16. Doping control analysis of intact rapid-acting insulin analogues in human urine by liquid chromatography-tandem mass spectrometry.
Thevis M; Thomas A; Delahaut P; Bosseloir A; Schänzer W
Anal Chem; 2006 Mar; 78(6):1897-903. PubMed ID: 16536426
[TBL] [Abstract][Full Text] [Related]
17. Analysis of tolvaptan and its metabolites in sports drug testing by high-performance liquid chromatography coupled to tandem mass spectrometry.
Rzeppa S; Viet LN
Drug Test Anal; 2016 Oct; 8(10):1090-1094. PubMed ID: 26768215
[TBL] [Abstract][Full Text] [Related]
18. "Dilute-and-inject" multi-target screening assay for highly polar doping agents using hydrophilic interaction liquid chromatography high resolution/high accuracy mass spectrometry for sports drug testing.
Görgens C; Guddat S; Orlovius AK; Sigmund G; Thomas A; Thevis M; Schänzer W
Anal Bioanal Chem; 2015 Jul; 407(18):5365-79. PubMed ID: 25925859
[TBL] [Abstract][Full Text] [Related]
19. Development of liquid chromatography-tandem mass spectrometry-based analytical assays for the determination of HIF stabilizers in preventive doping research.
Beuck S; Bornatsch W; Lagojda A; Schänzer W; Thevis M
Drug Test Anal; 2011; 3(11-12):756-70. PubMed ID: 22213684
[TBL] [Abstract][Full Text] [Related]
20. Screening for the synthetic cannabinoid JWH-018 and its major metabolites in human doping controls.
Möller I; Wintermeyer A; Bender K; Jübner M; Thomas A; Krug O; Schänzer W; Thevis M
Drug Test Anal; 2011 Sep; 3(9):609-20. PubMed ID: 20872894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
